BRIEF-Arena Pharmaceuticals, Eisai receive 'paragraph IV certification'
August 25, 2016 at 06:20 AM EDT
* Co and Eisai Inc have received a 'paragraph IV certification' notification with respect to patents for Belviq
BRIEF-Arena Pharmaceuticals, Eisai receive 'paragraph IV certification'August 25, 2016 at 06:20 AM EDT
* Co and Eisai Inc have received a 'paragraph IV certification' notification with respect to patents for Belviq
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|